4-Cholesten-3-one

4-Cholesten-3-one is a lipid of Sterol Lipids (ST) class. 4-cholesten-3-one is associated with abnormalities such as Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana and Xanthoma. The involved functions are known as CYP27A1activity, 25-hydroxycholesterol 7alpha-hydroxylase activity, Biochemical Pathway, Anabolism and Oxidation. 4-cholesten-3-one often locates in Mitochondria, Liver, Body tissue, Hepatic, Mitochondria and Endothelium of artery. The associated genes with 4-Cholesten-3-one are P4HTM gene, tryptones and Regulon. The related lipids are Cholestenones, 7-hydroxy-4-cholesten-3-one, cholest-4-en-3-one, 25-hydroxycholesterol and 24-hydroxycholesterol.

Cross Reference

Introduction

To understand associated biological information of 4-Cholesten-3-one, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 4-Cholesten-3-one?

4-Cholesten-3-one is suspected in Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana, Xanthoma, Rare Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with 4-Cholesten-3-one

Lipid pathways are not clear in current pathway databases. We organized associated pathways with 4-Cholesten-3-one through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 4-Cholesten-3-one?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 4-Cholesten-3-one?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 4-Cholesten-3-one?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 4-Cholesten-3-one?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 4-Cholesten-3-one?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 4-Cholesten-3-one

Download all related citations
Per page 10 20 50 100 | Total 397
Authors Title Published Journal PubMed Link
Bakken GA and Jurs PC QSARs for 6-azasteroids as inhibitors of human type 1 5alpha-reductase: prediction of binding affinity and selectivity relative to 3-BHSD. J Chem Inf Comput Sci pmid:11604025
pmid:
Jang S et al. Establishment of type II 5alpha-reductase over-expressing cell line as an inhibitor screening model. J. Steroid Biochem. Mol. Biol. pmid:17646096
Bonafè M et al. What studies on human longevity tell us about the risk for cancer in the oldest old: data and hypotheses on the genetics and immunology of centenarians. Exp. Gerontol. pmid:12470840
Gironés X and Carbó-Dorca R Molecular quantum similarity-based QSARs for binding affinities of several steroid sets. J Chem Inf Comput Sci pmid:12377008
BUCHER NL et al. Cholesterol biosynthesis in preparations of liver from normal, fasting, x-irradiated, cholesterol-fed, triton, or delta 4-cholesten-3-one-treated rats. 1959 J. Biol. Chem. pmid:13630891
PUDLES J and BLOCH K Conversion of 4-hydroxymethylene-Delta 7 cholesten-3-one to cholesterol. 1960 J. Biol. Chem. pmid:13738392
Schuster RE and Bennett RD A direct low temperature 1H and 19F nuclear magnetic resonance study of boron trifluoride complexes with 4-cholesten-3-one, 1(5beta)-androstene-3,17-dione, 5beta-androstane-3,17-dione, and obacunone. 1973 J. Org. Chem. pmid:4733449
Smith AG and Brooks CJ The mechanism of the isomerization of Cholest-5-en-3-one to cholest-4-en-3-one by cholesterol oxidase [proceedings]. 1977 Biochem. Soc. Trans. pmid:913789
Gallo LL et al. Enzymatic assay for cholesterol ester hydrolase activity. 1978 J. Lipid Res. pmid:712250
Aringer L 7-Hydroxylation of 3-oxygenated C27-, C28-, and C29-steroids in rat liver 18,000 g supernate. 1978 J. Lipid Res. pmid:731128
Nakagawa Y et al. Transfer of steroids and alpha-tocopherol between liposomal membranes. 1980 J. Biochem. pmid:6892636
Trinder P Oxidase determination of plasma cholesterol as cholest-4-en-3-one using iso-octane extraction. 1981 Ann. Clin. Biochem. pmid:6942786
Skrede S and Björkhem I Biosynthesis of cholestanol from intestinal 7 alpha-hydroxy-4-cholesten-3-one. 1982 J. Biol. Chem. pmid:7045120
Motlík K and Stárka L 4-Cholesten-3-one-induced lipoid hyperplasia of the adrenal cortex in rats. 1983 Acta Univ Carol Med (Praha) pmid:6637679
Stokes NA and Hylemon PB Characterization of delta 4-3-ketosteroid-5 beta-reductase and 3 beta-hydroxysteroid dehydrogenase in cell extracts of Clostridium innocuum. 1985 Biochim. Biophys. Acta pmid:3861198
Murphy PR et al. Binding of oxygenated cholesterol metabolites to antiestrogen binding sites from chicken liver. 1985 Biochem. Biophys. Res. Commun. pmid:3985957
Suzuki K et al. Characterization of cytotoxic steroids in human faeces and their putative role in the etiology of human colonic cancer. 1986 Cancer Lett. pmid:3802059
Kaul HK et al. Genotoxicity of two fecal steroids in murine colonic epithelium assessed by the sister chromatid exchange technique. 1987 Mutagenesis pmid:3328036
Yoshimoto T et al. Polyethylene glycol derivative-modified cholesterol oxidase soluble and active in benzene. 1987 Biochem. Biophys. Res. Commun. pmid:3479986
Buchmann MS et al. Metabolism of the cholestanol precursor cholesta-4,6-dien-3-one in different tissues. 1987 Biochim. Biophys. Acta pmid:3676336
Batta AK et al. Chromatographic separation of putative precursors of cholestanol. 1988 Jul-Aug Steroids pmid:3247666
Sugano S et al. Sensitive assay of cytochrome P450scc activity by high-performance liquid chromatography. 1989 Anal. Biochem. pmid:2610350
Wijnberg JB and de Groot A Synthesis and 13C-NMR analysis of 5 alpha- and 5 beta-cholestane-3,6-dione. 1989 Steroids pmid:2588307
Liu KZ et al. Oxidative status of lipoproteins in coronary disease patients. 1992 Am. Heart J. pmid:1736561
Contreras JA et al. Combination of an enzymatic method and HPLC for the quantitation of cholesterol in cultured cells. 1992 J. Lipid Res. pmid:1512516
Suzuki K Anti-obesity effect of cholest-4-en-3-one, an intestinal catabolite of cholesterol, on mice. 1993 J. Nutr. Sci. Vitaminol. pmid:8120678
Plemenitas A et al. Identification of progesterone binding sites in the plasma membrane of the filamentous fungus Cochliobolus lunatus. 1993 J. Steroid Biochem. Mol. Biol. pmid:8499335
Molnár I et al. Bacterial cholesterol oxidases are able to act as flavoprotein-linked ketosteroid monooxygenases that catalyse the hydroxylation of cholesterol to 4-cholesten-6-ol-3-one. 1993 Mol. Microbiol. pmid:8459768
Slotte JP and Ostman AL Oxidation/isomerization of 5-cholesten-3 beta-ol and 5-cholesten-3-one to 4-cholesten-3-one in pure sterol and mixed phospholipid-containing monolayers by cholesterol oxidase. 1993 Biochim. Biophys. Acta pmid:8431456
Slotte JP Direct observation of the action of cholesterol oxidase in monolayers. 1995 Biochim. Biophys. Acta pmid:7488639
Bartram HP et al. Effects of fish oil on fecal bacterial enzymes and steroid excretion in healthy volunteers: implications for colon cancer prevention. 1996 Nutr Cancer pmid:8837863
Lin HS et al. Synthesis of 4 alpha-(2-propenyl)-5,6-secocholestan-3 alpha-ol, a novel B-ring seco analog of the hypocholesterolemic agent 4 alpha-(2-propenyl)-5 alpha-cholestan-3 alpha-ol. 1998 Steroids pmid:9589554
Suzuki K et al. The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice. 1998 Bioorg. Med. Chem. Lett. pmid:9873500
Weststrate JA et al. Safety evaluation of phytosterol esters. Part 4. Faecal concentrations of bile acids and neutral sterols in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. 1999 Food Chem. Toxicol. pmid:10566877
Pang L et al. Membrane cholesterol modulates galanin-GalR2 interaction. 1999 Biochemistry pmid:10508403
Liu P et al. Presence of oxidized cholesterol in caveolae uncouples active platelet-derived growth factor receptors from tyrosine kinase substrates. 2000 J. Biol. Chem. pmid:10918056
Sampson NS Dissection of a flavoenzyme active site: the reaction catalyzed by cholesterol oxidase. 2001 Antioxid. Redox Signal. pmid:11761331
Yin Y et al. The presence of a hydrogen bond between asparagine 485 and the pi system of FAD modulates the redox potential in the reaction catalyzed by cholesterol oxidase. 2001 Biochemistry pmid:11705367
Niven SJ et al. Investigations of cholesterol transformation during sewage treatment: relevance to estrogen formation pathways? 2001 Sci. Total Environ. pmid:11712607
Shibata A et al. Genetic polymorphisms in the androgen receptor and type II 5 alpha-reductase genes in prostate enlargement. 2001 J. Urol. pmid:11547131
Samy TS et al. Divergent immune responses in male and female mice after trauma-hemorrhage: dimorphic alterations in T lymphocyte steroidogenic enzyme activities. 2001 Endocrinology pmid:11459798
Asada Y et al. 5 alpha-reductase type 2 is constitutively expressed in the dermal papilla and connective tissue sheath of the hair follicle in vivo but not during culture in vitro. 2001 J. Clin. Endocrinol. Metab. pmid:11397903
Stuart EB et al. Steroid hormone influence on brain calbindin-D(28K) in male prepubertal and ovariectomized rats. 2001 Brain Res. Dev. Brain Res. pmid:11506857
Charbonneau A and The VL Genomic organization of a human 5beta-reductase and its pseudogene and substrate selectivity of the expressed enzyme. 2001 Biochim. Biophys. Acta pmid:11342103
DellaGreca M et al. Solid-state photodimerization of cholest-4-en-3-one. 2001 J. Org. Chem. pmid:11300900
Platz EA Basic Science. 2001 Urology pmid:11273573
Nam RK et al. V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. 2001 Urology pmid:11164181
Wu AH et al. Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men. 2001 Cancer Epidemiol. Biomarkers Prev. pmid:11352865
Weber KS et al. Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague-Dawley rats. 2001 J. Endocrinol. pmid:11524239
Melcangi RC and Panzica G Steroids in the nervous system: a Pandora's box? 2001 Trends Neurosci. pmid:11421230
Griffin LD and Mellon SH Biosynthesis of the neurosteroid 3 alpha-hydroxy-4-pregnen-20-one (3 alpha hp), a specific inhibitor of FSH release. 2001 Endocrinology pmid:11606426
Hsing AW et al. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. 2001 Cancer Epidemiol. Biomarkers Prev. pmid:11588134
Riters LV et al. Seasonal variation in androgen-metabolizing enzymes in the diencephalon and telencephalon of the male European starling (Sturnus vulgaris). 2001 J. Neuroendocrinol. pmid:11737557
Haigh WG and Lee SP Identification of oxysterols in human bile and pigment gallstones. 2001 Gastroenterology pmid:11438500
Fritsch M et al. Sebocytes are the key regulators of androgen homeostasis in human skin. 2001 J. Invest. Dermatol. pmid:11348472
Chaler R et al. Bile acids and sterols in urban sewage treatment plants. 2001 J Chromatogr A pmid:11572384
Reichert W et al. Stable expression of human 5alpha-reductase type II in COS1 cells due to chromosomal gene integration: a novel tool for inhibitor identification. 2001 J. Steroid Biochem. Mol. Biol. pmid:11595508
Coulombe R et al. Oxygen access to the active site of cholesterol oxidase through a narrow channel is gated by an Arg-Glu pair. 2001 J. Biol. Chem. pmid:11397813
Walker BR Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence? 2001 Growth Horm. IGF Res. pmid:11527096
Shaw JC Hormonal therapies in acne. 2002 Expert Opin Pharmacother pmid:12083987
Yin Y et al. Construction of a catalytically inactive cholesterol oxidase mutant: investigation of the interplay between active site-residues glutamate 361 and histidine 447. 2002 Arch. Biochem. Biophys. pmid:12051668
Huynh H Induction of apoptosis in rat ventral prostate by finasteride is associated with alteration in MAP kinase pathways and Bcl-2 related family of proteins. 2002 Int. J. Oncol. pmid:12012013
Itoh K et al. Mutation screening for the 5alpha-reductase type 2 gene in Japanese men with idiopathic azoospermia. 2002 Fertil. Steril. pmid:12009375
Brady BM and Anderson RA Advances in male contraception. 2002 Expert Opin Investig Drugs pmid:11866663
Malik V and Pundir CS Determination of total cholesterol in serum by cholesterol esterase and cholesterol oxidase immobilized and co-immobilized on to arylamine glass. 2002 Biotechnol. Appl. Biochem. pmid:12074697
Wolfreys AM and Hepburn PA Safety evaluation of phytosterol esters. Part 7. Assessment of mutagenic activity of phytosterols, phytosterol esters and the cholesterol derivative, 4-cholesten-3-one. 2002 Food Chem. Toxicol. pmid:11893405
Hiort O et al. A novel homozygous disruptive mutation in the SRD5A2-gene in a partially virilized patient with 5alpha-reductase deficiency. 2002 Int. J. Androl. pmid:11869378
Silfen ME et al. 5 alpha-reductase and 11 beta-hydroxysteroid dehydrogenase activity in prepubertal Hispanic girls with premature adrenarche. 2002 J. Clin. Endocrinol. Metab. pmid:12364451
Nguyen DH and Taub D Cholesterol is essential for macrophage inflammatory protein 1 beta binding and conformational integrity of CC chemokine receptor 5. 2002 Blood pmid:12036855
Azzouzi AR et al. Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate. 2002 Eur. J. Endocrinol. pmid:12370109
Yang C et al. A49T, V89L and TA repeat polymorphisms of steroid 5alpha-reductase type II and breast cancer risk in Japanese women. 2002 Breast Cancer Res. pmid:12100746
Sojo MM et al. Rhodococcus erythropolis ATCC 25544 as a suitable source of cholesterol oxidase: cell-linked and extracellular enzyme synthesis, purification and concentration. 2002 BMC Biotechnol. pmid:11914155
Ribeiro ML et al. Allelic frequencies of six polymorphic markers for risk of prostate cancer. 2002 Braz. J. Med. Biol. Res. pmid:11847524
Schatzl G et al. Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men. 2002 Prostate pmid:12111704
Raynaud JP et al. Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon. 2002 J. Steroid Biochem. Mol. Biol. pmid:12477490
Carmina E Anti-androgens for the treatment of hirsutism. 2002 Expert Opin Investig Drugs pmid:11866665
Maeda Y et al. A simple, accurate, and sensitive assay method of dehydroepiandrosterone sulfate: application for quantitative determination in human breast cyst and duct fluids. 2002 Steroids pmid:11958788
Campbell SM et al. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. 2002 AIDS pmid:12441796
Prager N et al. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. 2002 J Altern Complement Med pmid:12006122
Pham H and Ziboh VA 5 alpha-reductase-catalyzed conversion of testosterone to dihydrotestosterone is increased in prostatic adenocarcinoma cells: suppression by 15-lipoxygenase metabolites of gamma-linolenic and eicosapentaenoic acids. 2002 J. Steroid Biochem. Mol. Biol. pmid:12589947
Zeigler-Johnson CM et al. Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4. 2002 Hum. Hered. pmid:12446983
Shibata A et al. Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis. 2002 Prostate pmid:12210487
Suzuki Y et al. 5Alpha-reductase type 2 genes in Japanese males do not appear to be associated with cryptorchidism. 2002 Fertil. Steril. pmid:12137870
Lemonde HA et al. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. 2003 Gut pmid:12970144
Nguyen DH and Taub DD Inhibition of chemokine receptor function by membrane cholesterol oxidation. 2003 Exp. Cell Res. pmid:14597406
Martin RM et al. Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings. 2003 J. Clin. Endocrinol. Metab. pmid:12843139
Shapiro J and Kaufman KD Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). 2003 J. Investig. Dermatol. Symp. Proc. pmid:12894990
Soma KK et al. Brain aromatase, 5 alpha-reductase, and 5 beta-reductase change seasonally in wild male song sparrows: relationship to aggressive and sexual behavior. 2003 J. Neurobiol. pmid:12884261
Ntais C et al. SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis. 2003 Cancer Epidemiol. Biomarkers Prev. pmid:12869400
Gupta Y et al. Kinetic analysis of LDL oxidation in IHD and IHD risk subjects in Indian population. 2003 Indian J Clin Biochem pmid:23105369
Nguyen PN et al. Changes in 5alpha-pregnane steroids and neurosteroidogenic enzyme expression in fetal sheep with umbilicoplacental embolization. 2003 Pediatr. Res. pmid:12930920
Torres JM et al. Semiquantitative RT-PCR method coupled to capillary electrophoresis to study 5alpha-reductase mRNA isozymes in rat ventral prostate in different androgen status. 2003 Mol. Cell. Biochem. pmid:12962150
Ji Q et al. Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. 2003 Prostate pmid:12539226
Yoshida T et al. Origin of oxysterols in hepatic bile of patients with biliary infection. 2003 Am. J. Gastroenterol. pmid:14572579
Wang GM et al. Effects of insulin-like growth factor I on steroidogenic enzyme expression levels in mouse leydig cells. 2003 Endocrinology pmid:12959969
Wiebe JP and Lewis MJ Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells. 2003 BMC Cancer pmid:12659654
Luo J et al. Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma. 2003 Prostate pmid:12949937
Abbiati G et al. Sequential amination/annulation/aromatization reaction of carbonyl compounds and propargylamine: a new one-pot approach to functionalized pyridines. 2003 J. Org. Chem. pmid:12946136
Sasaki G et al. Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients. 2003 J. Clin. Endocrinol. Metab. pmid:12843198